• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genomic and transcriptional Profiling of tumor infiltrated CD8 T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.肿瘤浸润性CD8 T细胞的基因组和转录谱分析揭示了肝细胞癌中抗肿瘤免疫的功能异质性。
Oncoimmunology. 2018 Nov 10;8(2):e1538436. doi: 10.1080/2162402X.2018.1538436. eCollection 2019.
2
TOX promotes the exhaustion of antitumor CD8 T cells by preventing PD1 degradation in hepatocellular carcinoma.TOX 通过阻止 PD1 降解促进肝癌中抗肿瘤 CD8 T 细胞耗竭。
J Hepatol. 2019 Oct;71(4):731-741. doi: 10.1016/j.jhep.2019.05.015. Epub 2019 Jun 5.
3
CD8 T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma.CD8 T 细胞介导乳香和没药在肝细胞癌中的抗肿瘤活性。
J Transl Med. 2018 May 21;16(1):132. doi: 10.1186/s12967-018-1508-5.
4
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
5
PD1 CD8 T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma.PD1 CD8 T 细胞与肝癌衰竭特征和不良临床结局相关。
J Immunother Cancer. 2019 Nov 29;7(1):331. doi: 10.1186/s40425-019-0814-7.
6
Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.阻断Tim-3或/和PD-1可逆转HBV相关肝细胞癌中肿瘤浸润淋巴细胞的功能障碍。
Bull Cancer. 2018 May;105(5):493-501. doi: 10.1016/j.bulcan.2018.01.018. Epub 2018 Mar 22.
7
Functional Heterogeneity of CD4 Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC.非小细胞肺癌中具有驻留记忆表型的 CD4 肿瘤浸润淋巴细胞的功能异质性。
Front Immunol. 2018 Nov 16;9:2654. doi: 10.3389/fimmu.2018.02654. eCollection 2018.
8
Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.肝细胞癌患者肿瘤浸润性CD8 + T细胞的临床病理特征及预后意义:一项荟萃分析。
Medicine (Baltimore). 2019 Jan;98(2):e13923. doi: 10.1097/MD.0000000000013923.
9
Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.肝细胞癌中肿瘤浸润淋巴细胞的表型分析
Hepatogastroenterology. 2007 Jul-Aug;54(77):1529-33.
10
Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma.肝细胞癌中抗肿瘤T细胞反应受损
Cancers (Basel). 2020 Mar 8;12(3):627. doi: 10.3390/cancers12030627.

引用本文的文献

1
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review.癌症免疫反应性的理解与治疗性调控进展:癌症免疫治疗学会(SITC)综述
J Immunother Cancer. 2025 Jan 16;13(1):e008876. doi: 10.1136/jitc-2024-008876.
2
Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.有效的抗病毒治疗通过减轻炎症和纤维化改善肝细胞癌免疫微环境中的免疫抑制活性。
Cancer Med. 2024 Dec;13(23):e70459. doi: 10.1002/cam4.70459.
3
The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells.乙型肝炎病毒相关性肝细胞癌中的适应性免疫应答的特征是乙型肝炎病毒特异性 T 细胞功能障碍和耗竭。
Viruses. 2024 Apr 29;16(5):707. doi: 10.3390/v16050707.
4
Identification of a disulfidptosis-related lncRNA signature for the prognostic and immune landscape prediction in head and neck squamous cell carcinoma.用于预测头颈部鳞状细胞癌预后和免疫格局的二硫化物依赖性细胞程序性坏死相关长链非编码RNA特征的鉴定
Discov Oncol. 2024 Mar 14;15(1):75. doi: 10.1007/s12672-024-00932-2.
5
Peripheral Blood CD8+T Cell as a Prognostic Biomarker for Hospitalised COVID-19 Patients Without Antiviral Treatment.外周血CD8+T细胞作为未接受抗病毒治疗的住院COVID-19患者的预后生物标志物
Infect Drug Resist. 2024 Jan 12;17:109-117. doi: 10.2147/IDR.S432283. eCollection 2024.
6
Identification of CBPA as a New Inhibitor of PD-1/PD-L1 Interaction.鉴定 CBPA 为 PD-1/PD-L1 相互作用的新抑制剂。
Int J Mol Sci. 2023 Feb 16;24(4):3971. doi: 10.3390/ijms24043971.
7
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗下乙型肝炎病毒相关晚期肝细胞癌患者的乙型肝炎病毒 DNA 水平与总生存期的关系。
Cancer Immunol Immunother. 2023 Feb;72(2):385-395. doi: 10.1007/s00262-022-03254-w. Epub 2022 Jul 30.
8
Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.原发性肝癌中的三级淋巴结构:争议无法掩盖希望。
Front Immunol. 2022 Jun 29;13:870458. doi: 10.3389/fimmu.2022.870458. eCollection 2022.
9
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges.肝细胞癌中的免疫检查点抑制剂:当前进展与挑战
Front Oncol. 2021 Oct 22;11:737497. doi: 10.3389/fonc.2021.737497. eCollection 2021.
10
Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.基于基因共表达网络分析鉴定肝细胞癌中的免疫浸润细胞相关生物标志物。
Diagn Pathol. 2021 Jul 4;16(1):57. doi: 10.1186/s13000-021-01118-y.

本文引用的文献

1
Human CD26 T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence.人 CD26 T 细胞通过增强迁移和持久性引发针对多种恶性肿瘤的肿瘤免疫。
Nat Commun. 2017 Dec 6;8(1):1961. doi: 10.1038/s41467-017-01867-9.
2
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.单细胞测序揭示肝癌浸润 T 细胞景观。
Cell. 2017 Jun 15;169(7):1342-1356.e16. doi: 10.1016/j.cell.2017.05.035.
3
Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.抗病毒治疗可抑制乙肝病毒相关复发性肝细胞癌再次肝切除术后的病毒激活并提高生存率。
J Am Coll Surg. 2017 Mar;224(3):283-293.e4. doi: 10.1016/j.jamcollsurg.2016.11.009. Epub 2016 Dec 5.
4
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.免疫原性抗原的密度并不能解释黑色素瘤中T细胞炎症性肿瘤微环境的存在与否。
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7759-E7768. doi: 10.1073/pnas.1609376113. Epub 2016 Nov 11.
5
RNAcentral: a comprehensive database of non-coding RNA sequences.RNAcentral:一个非编码RNA序列的综合数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D128-D134. doi: 10.1093/nar/gkw1008. Epub 2016 Oct 28.
6
The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.调节性树突状细胞标记物 C1q 是一种有效的过敏炎症抑制剂。
Mucosal Immunol. 2017 May;10(3):695-704. doi: 10.1038/mi.2016.87. Epub 2016 Oct 12.
7
MAIT cells: new guardians of the liver.MAIT 细胞:肝脏的新守护者。
Clin Transl Immunology. 2016 Aug 19;5(8):e98. doi: 10.1038/cti.2016.51. eCollection 2016 Aug.
8
Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.原发性黑色素瘤中肿瘤浸润淋巴细胞组成的免疫异质性。
Hum Pathol. 2016 Nov;57:116-125. doi: 10.1016/j.humpath.2016.07.008. Epub 2016 Jul 26.
9
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.肿瘤内 CD3 和 CD8 T 细胞密度与 HCC 无复发生存相关。
Cancer Immunol Res. 2016 May;4(5):419-30. doi: 10.1158/2326-6066.CIR-15-0110. Epub 2016 Mar 11.
10
Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.趋化因子受体CXCR3对晚期胃癌中与良好预后相关的肿瘤浸润淋巴细胞募集的影响。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14725-32. eCollection 2015.

肿瘤浸润性CD8 T细胞的基因组和转录谱分析揭示了肝细胞癌中抗肿瘤免疫的功能异质性。

Genomic and transcriptional Profiling of tumor infiltrated CD8 T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.

作者信息

Li Zhenli, Chen Geng, Cai Zhixiong, Dong Xiuqing, Qiu Liman, Xu Haipo, Zeng Yongyi, Liu Xiaolong, Liu Jingfeng

机构信息

The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.

The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, China.

出版信息

Oncoimmunology. 2018 Nov 10;8(2):e1538436. doi: 10.1080/2162402X.2018.1538436. eCollection 2019.

DOI:10.1080/2162402X.2018.1538436
PMID:30713796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343808/
Abstract

As key players in HCC antitumor response, the functions of tumor infiltrated CD8 T cells are significantly affected by surrounding microenvironment. A detailed profiling of their genomic and transcriptional changes could provide valuable insights for both future immunotherapy development and prognosis evaluation. We performed whole exome and transcriptome sequencing on tumor infiltrated CD8 T cells and CD8 T cells isolated from other tissue origins (peritumor tissues and corresponding PBMCs) in eight treatment-naive HCC patients. The results demonstrated that transcriptional changes, rather than genomic alterations were the main contributors to the functional alterations of CD8 T cells in the process of tumor progression. The origins of CD8 T cells defined their transcriptional landscape, while the tumor infiltrated CD8 T cells shared more similarity with peritumor-derived CD8 T cells compared with those CD8 T cells in blood. In addition, tumor infiltrated CD8 T cells also showed larger transcriptional heterogeneity among individuals, which was modulated by clinical features such as HBV levels, preoperative anti-viral treatment and the degree of T cell infiltration. We also identified multiple inter-connected pathways involved in the activation and exhaustion of tumor infiltrated CD8 T cells, among which IL-12 mediated pathway could dynamically reflect the functional status of CD8 TILs and activation of this pathway indicated a better prognosis. Our results presented an overview picture of CD8 TILs' genomic and transcriptional landscape and features, as well as how the functional status of CD8 TILs correlated with patients' clinical course.

摘要

作为肝癌抗肿瘤反应的关键参与者,肿瘤浸润性CD8 T细胞的功能受到周围微环境的显著影响。对其基因组和转录变化进行详细分析可为未来免疫治疗的发展和预后评估提供有价值的见解。我们对8例未经治疗的肝癌患者的肿瘤浸润性CD8 T细胞以及从其他组织来源(瘤旁组织和相应外周血单核细胞)分离出的CD8 T细胞进行了全外显子组和转录组测序。结果表明,转录变化而非基因组改变是肿瘤进展过程中CD8 T细胞功能改变的主要原因。CD8 T细胞的来源决定了其转录图谱,与血液中的CD8 T细胞相比,肿瘤浸润性CD8 T细胞与瘤旁来源的CD8 T细胞具有更多相似性。此外,肿瘤浸润性CD8 T细胞在个体间也表现出更大的转录异质性,这种异质性受乙肝病毒水平、术前抗病毒治疗和T细胞浸润程度等临床特征的调节。我们还确定了多个与肿瘤浸润性CD8 T细胞激活和耗竭相关的相互关联的通路,其中IL-12介导的通路可动态反映CD8 TILs的功能状态,该通路的激活预示着更好的预后。我们的研究结果展示了CD8 TILs的基因组和转录图谱及特征的全貌,以及CD8 TILs的功能状态与患者临床病程的相关性。